Abstract
Speech and language impairment is core in Koolen-de Vries syndrome (KdVS), yet only one study has examined this empirically. Here we define speech, language, and functional/adaptive behaviour in KdVS; while deeply characterising the medical/neurodevelopmental phenotype in the largest cohort to date. Speech, language, literacy, and social skills were assessed using standardised measures, alongside an in-depth health and medical questionnaire. 81 individuals with KdVS were recruited (35 female, mean age 9y 10mo), 56 of whom harboured the typical 500–650 kb 17q21.31 deletion. The core medical phenotype was intellectual disability (largely moderate), eye anomalies/vision disturbances, structural brain anomalies, dental problems, sleep disturbance, musculoskeletal abnormalities, and cardiac defects. Most were verbal (62/81, 76.5%), while minimally-verbal communicators used alternative and augmentative communication (AAC) successfully in spite of speech production delays. Speech was characterised by apraxia (39/61, 63.9%) and dysarthria (28/61, 45.9%) in verbal participants. Stuttering was described in 36/47 (76.6%) verbal participants and followed a unique trajectory of late onset and fluctuating presence. Receptive and expressive language abilities were commensurate with one another, but literacy skills remained a relative weakness. Social competence, successful behavioural/emotional control, and coping skills were areas of relative strength, while communication difficulties impacted daily living skills as an area of comparative difficulty. Notably, KdVS individuals make communication gains beyond childhood and should continue to access targeted therapies throughout development, including early AAC implementation, motor speech therapy, language/literacy intervention, as well as strategies implemented to successfully navigate activities of daily living that rely on effective communication.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
References
Koolen DA, Vissers LE, Pfundt R, de Leeuw N, Knight SJ, Regan R, et al. A new chromosome 17q21.31 microdeletion syndrome associated with a common inversion polymorphism. Nat Genet. 2006;38:999–1001.
Koolen DA, Sharp AJ, Hurst JA, Firth HV, Knight SJ, Goldenberg A, et al. Clinical and molecular delineation of the 17q21.31 microdeletion syndrome. J Med Genet. 2008;45:710–20.
Koolen DA, Kramer JM, Neveling K, Nillesen WM, Moore-Barton HL, Elmslie FV, et al. Mutations in the chromatin modifier gene KANSL1 cause the 17q21.31 microdeletion syndrome. Nat Genet. 2012;44:639–41.
Zollino M, Orteschi D, Murdolo M, Lattante S, Battaglia D, Stefanini C, et al. Mutations in KANSL1 cause the 17q21.31 microdeletion syndrome phenotype. Nat Genet. 2012;44:636–8.
Koolen DA, Pfundt R, Linda K, Beunders G, Veenstra-Knol HE, Conta JH, et al. The Koolen-de Vries syndrome: a phenotypic comparison of patients with a 17q21.31 microdeletion versus a KANSL1 sequence variant. Eur J Hum Genet. 2016;24:652–9.
Koolen DA, Morgan A, de Vries BBA. Koolen-de Vries syndrome. [Updated 2019 Jun 13]. In: Adam MP, Everman DB, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington; 2010.
Morgan AT, Haaften LV, van Hulst K, Edley C, Mei C, Tan TY, et al. Early speech development in Koolen de Vries syndrome limited by oral praxis and hypotonia. Eur J Hum Genet. 2018;26:75–84.
Egger JI, Wingbermühle E, Verhoeven WM, Dijkman M, Radke S, de Bruijn ER, et al. Hypersociability in the behavioral phenotype of 17q21.31 microdeletion syndrome. Am J Med Genet A 2013;161A:21–6. https://doi.org/10.1002/ajmg.a.35652
Morgan A, Braden R, Wong MMK, Colin E, Amor D, Liégeois F, et al. Speech and language deficits are central to SETBP1 haploinsufficiency disorder. Eur J Hum Genet. 2021;29:1216–25. https://doi.org/10.1038/s41431-021-00894-x
Morison LD, Braden RO, Amor DJ, Brignell A, van Bon BWM, Morgan AT. Social motivation a relative strength in DYRK1A syndrome on a background of significant speech and language impairments. Eur J Hum Genet. 2022; 30:800–81.
Sparrow SS, Cicchetti DV, Saulnier CA. Vineland adaptive behaviour scales. 3rd ed. Bloomington, IN: Pearson; 2016.
Bishop DV. Children’s communication checklist (CCC-2). London: Pearson; 2003.
Wetherby AM, Prizant BM. Communication and symbolic behavior scales: developmental profile. Baltimore, MD: Paul H. Brookes; 2002.
Dodd BH, Hua Z, Crosbie S, Holm A, Ozanne A. Diagnostic evaluation of articulation and phonology. London: The Psychological Corporation; 2002.
Duffy JR. Motor speech disorders: substrates, differential diagnosis and management. St. Louis, MO: Mosby; 2013.
Braden RO, Boyce JO, Stutterd CA, Pope K, Goel H, Leventer RJ, et al. Speech, language, and oromotor skills in patients with polymicrogyria. Neurology. 2021;96:e1898–e1912.
Mei C, Fedorenko E, Amor DJ, Boys A, Hoeflin C, Carew P, et al. Deep phenotyping of speech and language skills in individuals with 16p11.2 deletion. EJHG. 2018;26:676–86.
Gozzard H, Baker E, McCabe P. Children’s productions of polysyllables. ACQuiring Knowledge in Speech, Language and Hearing. 2006;8:113–6.
American Speech-Language-Hearing Association (ASHA). Childhood Apraxia of Speech [Internet]. Rockville, MD: ASHA; 2021.
Onslow M, Webber M, Harrison E, Arnott S, Bridgman K, Carey B, et al.The Lidcombe Program Treatment Guide. Lidcombe Program Trainers Consortium (2017).
Van Borsel J, Tetnowski JA. Fluency disorders in genetic syndromes. J Fluen Disord. 2007;32:279–96.
Yairi E, Ambrose N. Epidemiology of stuttering: 21st century advances. J Fluen Disord. 2013;38:66–87. https://doi.org/10.1016/j.jfludis.2012.11.002
Boyce JO, Jackson VE, van Reyk O, Parker R, Vogel AP, Eising E, et al. Self-reported impact of developmental stuttering across the lifespan. Dev Med Child Neurol. 2022;64:1297–306.
Kefalianos E, Onslow M, Packman A, Vogel A, Pezic A, Mensah F, et al. The history of stuttering by 7 years of age: follow-up of a prospective community cohort. J Speech Lang Hear Res. 2017;60:2828–39. https://doi.org/10.1044/2017_JSLHR-S-16-0205
Howell P, Davis S, Williams R. Late childhood stuttering. JSLHR. 2008;51:669–87.
Tichenor SE, Yaruss JS. Variability of stuttering: behavior and impact. Am J Speech Lang Pathol. 2021;30:75–88.
Morgan A, Liégeois F, Vargha-Khadem F. Motor speech profile in relation to site of brain pathology: a developmental perspective. In Maassen B, van Lieshout P, editors. Speech motor control: new developments in basic and applied research. Oxford: Oxford Academic; 2010).
Brignell A, Krahe M, Downes M, Kefalianos E, Reilly S, Morgan A. Interventions for children and adolescents who stutter: a systematic review, meta-analysis, and evidence map. J Fluen Disord. 2021;70:105843 https://doi.org/10.1016/j.jfludis.2021.105843
Brignell A, Krahe M, Downes M, Kefalianos E, Reilly S, Morgan AT. A systematic review of interventions for adults who stutter. J Fluen Disord. 2020;64:105766 https://doi.org/10.1016/j.jfludis.2020.105766
Franken MC, de Sonneville-Koedoot C, Stolk E, Rietveld ACM, Bouwmans-Frijters C. Comparing a demands and capacities model approach and the Lidcombe program for pre-school stuttering children: the restart randomised trail. Procedia-Soc Behav Sci. 2015;193:287–8.
Acknowledgements
We would like to thank all individuals with Koolen-de Vries syndrome and their families who took part in this research study. Provided by National Health and Medical Research Council (NHMRC) Centre of Research Excellence in Speech and Language #1116976 (AM, DA).
Author information
Authors and Affiliations
Contributions
MSJ: collected data, analysed data, interpreted data and wrote/edited manuscript. OvR, DAK and BBAdV: collected data, analysed data and edited manuscript. DJA and ATM: designed and conceptualised the study, interpreted data, directed the project and wrote/edited manuscript.
Corresponding author
Ethics declarations
Ethical approval
Ethical approval was obtained through the Royal Children’s Hospital, Melbourne, Human Research Ethics Committee (HREC #37353). Written informed consent was obtained from the participant or their parents/legal guardian in the case of minors or adults with intellectual disabilities.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
St John, M., van Reyk, O., Koolen, D.A. et al. Expanding the speech and language phenotype in Koolen-de Vries syndrome: late onset and periodic stuttering a novel feature. Eur J Hum Genet 31, 531–540 (2023). https://doi.org/10.1038/s41431-022-01230-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41431-022-01230-7